Access our library of publications about the ReducerTMhere >
This device is currently only available in the EU.
How the Reducer Works
A Reducer Success Story
For more information on Reducer for all European countries outside of Germany, kindly message Mark Niggli, VP European Sales and Marketing, here.
For more information on Reducer specific to Germany, kindly contact Andreas Mayer, Senior Director DACH, here.
Treats a large and growing population of patients suffering from refractory angina who have limited options
Currently CE Marked
COSIRA data showed patients treated with Reducer were 2.3 times more likely to see an improvement of two Canadian Cardiovascular Society (CCS) functional classification as compared to the control arm (n = 104, p value = 0.024).
Note: The CCS class is a functional classification used to stratify the severity of angina by evaluating angina symptoms with activity levels. N Eng J Med 2015;372:519-527